Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-18

FDA Approved: CYANOCOBALAMIN — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approves cyanocobalamin (generic) from Somerset Therapeutics, LLC via Original Application (ANDA209429).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cyanocobalamin (generic) (cyanocobalamin)

Snippet

ORIG AP for CYANOCOBALAMIN (CYANOCOBALAMIN)